Mehmet Kahraman
Inventor
Stats
- 22 US patents issued
- 46 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 22 US Patents Issued
- 46 US Applications Filed
- 414 Total Citation Count
- Dec 7, 2023 Most Recent Filing
- Oct 15, 2002 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
THE JOHNS HOPKINS UNIVERSITY | 2
2 4 | 2002
2003 2006 |
Gardiner, Elizabeth M.M. | 2
| 2007
|
KALYRA PHARMACEUTICALS, INC. | 1
| 2015
|
Genentech, Inc. | 1
2 8 5 1 | 2011
2014 2015 2016 2017 |
KALYPSYS, INC. | 2
1 2 4 1 | 2005
2006 2007 2008 2009 |
Cyctochroma Inc. | 1
| 2006
|
SERAGON PHARMACEUTICALS, INC. | 6
6 3 2 | 2011
2012 2013 2014 |
OPKO IRELAND GLOBAL HOLDINGS, LTD. | 2
2 4 | 2002
2003 2006 |
Inventor Addresses
Address | Duration |
---|---|
Baltimore, MD | Jan 03, 06 - Sep 28, 06 |
Baltimore, MD, US | Sep 11, 03 - Jul 05, 11 |
La Jolla, CA, US | Mar 22, 12 - Feb 04, 25 |
San Diego, CA | Jul 27, 06 - Jan 24, 08 |
San Diego, CA, US | Jan 29, 09 - Feb 08, 22 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 39 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 16 |
C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 9 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
12213976 | 2025 | Compounds and methods for treating oxalate-related diseases | 0 |
12162870 | 2024 | Anticancer compounds | 0 |
2024/0226,096 | 2024 | TREATMENT OF MYELOPROLIFERATIVE DISEASES AND DISORDERS WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN | 0 |
2024/0217,952 | 2024 | TREATMENT OF GRAFT-VERSUS-HOST DISEASE WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN | 0 |
2024/0208,939 | 2024 | TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.